Yao Lin
Chongqing, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor.
Journal: Cell
Published: September 07, 2023
Chiral aldehyde catalysis enables direct asymmetric α-substitution reaction of N-unprotected amino acids with halohydrocarbons.
Journal: Chemical science
Published: March 10, 2023
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Journal: Vaccine
Published: January 28, 2023
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy.
Journal: Nature cancer
Published: January 17, 2023
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 11, 2022
A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
Journal: Signal transduction and targeted therapy
Published: November 16, 2021
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody.
Journal: Frontiers in immunology
Published: August 01, 2021
The Epigenetic Regulator EZH2 Instructs CD4 T Cell Response to Acute Viral Infection via Coupling of Cell Expansion and Metabolic Fitness.
Journal: Journal of virology
Published: August 23, 2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Journal: Signal transduction and targeted therapy
Published: June 23, 2020
Last Updated: 09/26/2026